There was an increasing trend in UCA1 levels from normal ovarian tissues to cisplatin-sensitive ovarian cancer tissues and then to cisplatin-resistant ovarian cancer tissues, and the differences among the three groups were significant ( Figure 1 C; p < 0.01).
← all excerpts
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
1
—
—